Literature DB >> 19162347

Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin.

Dania Mohty1, Philippe Pibarot, Jean-Pierre Després, Amélie Cartier, Benoit Arsenault, Frédéric Picard, Patrick Mathieu.   

Abstract

BACKGROUND: Aortic stenosis (AS) is considered as an atherosclerotic related process. However, there are uncertainties whether AS in the elderly is associated with the same pathophysiological processes as in younger patients. We hypothesized that the metabolic determinants of the valvular inflammatory and calcifying processes occurring in elderly patients are different from those observed earlier in life.
METHODS: Among 114 patients operated for a severe AS, a complete plasma lipid blood profile and plasma levels of adipokines (resistin, leptin) were determined. The calcium content of the aortic valve was measured and valvular inflammation was quantified.
RESULTS: Elderly patients (>or=70 years) had significantly lower LDL-C (p=0.02), lower LDL-C associated with small size particles (LDL-C <255 A) (p=0.003), and higher HDL peak particle size than younger patients (p=0.03). In addition, elderly patients had increased plasma leptin (p=0.04) and resistin (p=0.0004) levels compared to the middle-aged group (<70 years). In the elderly patients, higher plasma resistin blood levels were associated with increased valve calcium content and inflammation.
CONCLUSION: The lipid profile of elderly patients was found less atherogenic than that of middle-aged patients. On the other hand, older patients with AS had higher plasma level of resistin which was associated with the degree of valvular calcification and inflammation. These results suggest that, beyond lipid model of atherosclerosis, age-related processes affecting resistin blood levels may also be involved in the late development of AS. Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162347     DOI: 10.1016/j.ijcard.2008.12.068

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

Review 1.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

2.  RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing.

Authors:  Sandra Guauque-Olarte; Arnaud Droit; Joël Tremblay-Marchand; Nathalie Gaudreault; Dimitri Kalavrouziotis; Francois Dagenais; Jonathan G Seidman; Simon C Body; Philippe Pibarot; Patrick Mathieu; Yohan Bossé
Journal:  Physiol Genomics       Date:  2016-08-05       Impact factor: 3.107

Review 3.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

4.  Severe degenerative aortic stenosis with preserved ejection fraction does not change adipokines serum levels.

Authors:  Katarzyna Mizia-Stec; Tomasz Bochenek; Błażej Kusz; Magdalena Mizia-Szubryt; Agnieszka Sikora-Puz; Klaudia Gieszczyk-Strózik
Journal:  Cardiol J       Date:  2017-11-23       Impact factor: 2.737

Review 5.  Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk.

Authors:  Patrick Mathieu; Marie-Chloé Boulanger; Jean-Pierre Després
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 6.  Calcific aortic stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot
Journal:  Nat Rev Dis Primers       Date:  2016-03-03       Impact factor: 52.329

7.  Sirt1 inhibits resistin expression in aortic stenosis.

Authors:  Sophie Carter; Stéphanie Miard; Catherine Roy-Bellavance; Louise Boivin; Zhuo Li; Philippe Pibarot; Patrick Mathieu; Frédéric Picard
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  Association of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients.

Authors:  Eitaro Nakashima; Atsuko Watarai; Takayoshi Tsukahara; Yoji Hamada; Keiko Naruse; Hideki Kamiya; Jiro Kato; Norihiro Kato; Makoto Tomita; Yutaka Oiso; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2010-08-02       Impact factor: 4.232

9.  CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients.

Authors:  Abdullah Ozkok; Riza Atas; Suzan Adin Cinar; Akar Yilmaz; Esin Aktas; Gunnur Deniz; Alaattin Yildiz
Journal:  BMC Nephrol       Date:  2017-07-26       Impact factor: 2.388

10.  Relevance Study on Cerebral Infarction and Resistin Gene Polymorphism in Chinese Han Population.

Authors:  Aijuan Yan; Gaoyu Cai; Ningzhen Fu; Yulan Feng; Jialan Sun; Yiming Maimaiti; Weijun Zhou; Yi Fu
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.